Physician profile
David E Sausner
NPI 1689665069
$3,352.03
in general payments reported to CMS, 2019-2025
17 companies · $579 in 2025
The $579 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $120 · 2021: $568 · 2022: $405 · 2023: $555 · 2024: $701 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,817 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,817.30 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,122.55 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $296.95 | 2022-2025 | Vyzulta, Infuse, Miebo |
| Sun Pharmaceutical Industries INC. | $252.14 | 2023-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $248.67 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $199.92 | 2019-2023 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $183.59 | 2024-2025 | Xdemvy |
| Coopervision INC. | $173.61 | 2019-2023 | Myday Contact Lens |
| Kala Pharmaceuticals, INC. | $146.56 | 2021 | |
| Allergan, INC. | $132.58 | 2021-2022 | |
| Dompe US, INC. | $122.19 | 2025 | Oxervate |
| Amgen INC. | $122.19 | 2025 | Tepezza |
| Biotissue Holdings INC. | $118.68 | 2022-2023 | |
| Harrow Eye, LLC | $81.58 | 2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $54.00 | 2019 | |
| Sight Sciences, INC. | $46.87 | 2022-2023 | Tearcare System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $29.31 | 2022 | |
| Shire North American Group INC | $20.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sausner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.